Wednesday, Apr 21, 2021

La vacuna AstraZaneca fue aprobada este viernes por la Agencia Europea de Medicamentos

PAHO: Panama will receive 200,000-300,000 doses of the AstraZeneca vaccine in February

Gerardo Alfaro, representative of the Pan American Health Organization (PAHO) confirmed this Saturday to Telemetro that Panama will receive, through the COVAX mechanism, between 216,000 and 364,000 doses of the AztraZeneca / Oxford vaccine in mid-February.
Regarding this, the health authorities indicated that with the arrival of the second shipment of the Pfizer vaccine, the second doses will be completed for health personnel already vaccinated and with AstraZeneca the first-line health professionals who take care of the COVID-19 patients.

However, the health authorities assure that they have not confirmed the number of doses of the AstraZeneca vaccine that will arrive in the country between February and March.

The Minister of Foreign Affairs, Erika Mouynes had confirmed on Friday, January 29, that the next batch of vaccines against COVID-19 from the pharmaceutical company Pfizer would be arriving in the country in the week of February 15.

Progressively, the US pharmaceutical company will be sending other batches of the vaccine every week until the 450,000 agreed doses are met, declared the Chancellor.

So far, Panama has only received a first batch with 12,840 doses of Pfizer's vaccine against the coronavirus on January 20, and later began the vaccination campaign in health personnel who care for patients with COVID-19.

Regarding the British vaccine, it should be noted that the European Medicines Agency (EMA) recommended this Friday, January 29, the authorization of the AstraZeneca vaccine against COVID-19 for those over 18 years of age, while concern grows around the world about the slowness in vaccination and the new variants of the coronavirus.

Panama at the beginning of January 2021 had already made payments to three vaccine suppliers such as Pfizer, AstraZeneca and COVAX, according to the Minister of Health, Luis Sucre.

Related Articles